ChemChina's massive $43 billion acquisition of Syngenta AG (ADR) SYT has dominated financial headlines in early 2016, but seems to have dropped out of the spotlight as of late.
The mega-deal made headlines again on Wednesday as Syngenta's CEO John Ramsay said a regulatory review of the acquisition is on track to close by the end of the year.
Related Link: ChemChina Looking To Raise $35 Billion In Loans To Help Finance Takeover Of Syngenta
"We're still very much on course for all regulatory reviews," Ramsay said in an interview with The Wall Street Journal.
However, the deal faces significant scrutiny, especially in the U.S. given Syngenta's chemical factories in the country. As part of the regulatory process, the deal needs to be approved by the Committee on Foreign Investment for any national security related concerns.
Shares of Syngenta were trading lower by around 1 percent mid-Wednesday afternoon.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
